Table 2.
The study of correlation grouping and heterogeneity between BMD and BV/TV
| Subground | Standardized mean difference (95% CI) | I2 | P |
|---|---|---|---|
| BMD | |||
| Type of cells | |||
| BMSC | 1.44 [0.60, 2.29] | 66% | < 0.05 |
| ADSC | 3.34 [1.13, 5.55] | 72% | < 0.05 |
| DPSC | 1.90 [0.27, 3.54] | - | < 0.05 |
| Transplantation pathways | |||
| Tail vein injection | 1.86 [0.17, 3.56] | 78% | < 0.05 |
| Local injectable fillers | 2.41 [1.37, 3.44] | 51% | < 0.05 |
| Peritoneal cavity Intraperitoneal injection | 1.17 [0.09, 2.24] | 47% | < 0.05 |
| Modifier genes | |||
| CXCR4 | 0.43 [−0.24, 1.11] | 0% | 0.21 |
| BMP2 | 0.43 [−0.24, 1.11] | 59% | < 0.05 |
| Others | 2.63 [1.23, 4.03] | 72% | < 0.05 |
| BV/TV | |||
| Type of cells | |||
| BMSC | 2.80 [1.20, 4.41] | 82% | < 0.05 |
| ADSC | 3.34 [1.13, 5.55] | 72% | < 0.05 |
| DPSC | 1.90 [0.27, 3.54] | - | < 0.05 |
| Transplantation pathways | |||
| Tail vein injection | 2.26 [0.36, 4.16] | 84% | < 0.05 |
| Local injectable fillers | 2.39 [0.81, 3.98] | 80% | < 0.05 |
| Peritoneal cavity Intraperitoneal injection | 0.91 [−0.45, 2.27] | 47% | 0.19 |
| Modifier genes | |||
| CXCR4 | - | - | - |
| BMP2 | 2.12 [0.83, 3.40] | 59% | < 0.05 |
| Others | 3.03 [1.41, 4.64] | 79% | < 0.05 |